Search
Announcement: Jincheng Pharmaceutical Subsidiary Renews and Modifies Tobacco Monopoly Production License
2025-07-18 /
Read about 0 minute
Author：小编
Jincheng Pharmaceutical's wholly-owned subsidiary, Jincheng Pharmaceutical and Chemical, has recently secured a renewed and modified Tobacco Monopoly Production Enterprise License. This license extension runs through June 30, 2028, and includes an increase in the approved annual production capacity for nicotine intended for electronic cigarettes to a maximum of 200 tons. This development is expected to have a favorable impact on the company's overall performance.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
